Davion Healthcare Plc Ordinary Shares (DAVI)

Is Davion Healthcare Plc Ordinary Shares (DAVI) A Buy Now?

According to our latest analysis, DAVI could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on DAVI, as trading bullish markets is always a lot easier

1. RSI (Relative Strength Index): The RSI(14) value of 0.00 indicates that DAVI is oversold. This indicates that DAVI price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
2. STOCH (Stochastic Oscillator): The STOCH value of 0.00 indicates that DAVI is oversold. This indicates that DAVI price is at or near the lowest level over a specified lookback period.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.00 indicates that DAVI is oversold. This suggests that DAVI price is at or near the lowest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 0.00 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
5. CCI (Commodity Channel Index): A CCI(14) value of 0.00 indicates that DAVI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term DAVI price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Davion Healthcare Plc Ordinary Shares financial reports and earnings history, Davion Healthcare Plc Ordinary Shares (DAVI) stock could reach $318.52 by 2030, $1,098.91 by 2040 and $1,874.81 by 2050. See the projected annual prices until 2050 of the Davion Healthcare Plc Ordinary Shares stock below:

• Davion Healthcare Plc Ordinary Shares (DAVI) is expected to reach an average price of $711.60 in 2035, with a high prediction of $708.71 and a low estimate of $318.04. This indicates an +47,658% change from the last recorded price of $1.49.
• Davion Healthcare Plc Ordinary Shares (DAVI) stock is projected to chart a bullish course in 2040, with an average price target of $1,101.80, representing an +73,846% change from its current level. The forecast ranges from a conservative $513.78 to a sky-high $1,098.91.
• Our analysts predict Davion Healthcare Plc Ordinary Shares (DAVI) to change +50,083% by 2045, soaring from $709.53 to an average price of $747.73, potentially reaching $1,484.61. While $709.53 is the low estimate, the potential upside is significant.
• Davion Healthcare Plc Ordinary Shares (DAVI) stock is expected to climb by 2050, reaching an average of $943.47, a +63,220% change from its current level. However, a wide range of estimates exists, with high and low targets of $1,874.81 and $905.28, respectively, highlighting the market's uncertainty.

Davion Healthcare Plc Ordinary Shares Stock (DAVI) Year by Year Forecast